ONCT 1.65 (+11.49%)
US68236P1075BiotechnologyBiotechnology

Oncternal Therapeutics (ONCT) Financial Metrics

This table shows a selected set of financial data points of Oncternal Therapeutics (ONCT). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -13.43 0 -0.8 31.75M -0.75 0 -32.16M -41.71M -39.48M 6.7M
2022 -16.79 0 -0.06 2.63M -0.54 1.49M -36.7M -44.95M -44.17M 37.14M
2021 -12.71 0 -0.18 5.6M -0.3 4.32M -26.59M -31.37M -31.33M 90.77M
2020 -16.97 0 -0.29 4.97M -0.25 3.38M -17.5M -17.54M -17.23M 116.74M
2019 -3.31 0 -1.19 40.8M -1.29 2.43M -16.75M -14.83M -34.19M 20.05M
2018 -11.52 0 -0.47 18.21M -0.99 0 -39.35M -38.37M -38.42M 28.26M
2017 -12.22 0 -7.28 221.68M -0.86 0 -23.46M -30.39M -30.44M 15.82M
2016 -8.52 0 -4.34 76.87M -0.63 0 -20.87M -17.7M -17.72M 8.91M
2015 -8.86 0 -5.53 103.44M -0.45 0 -20.04M -18.66M -18.7M 14.06M
2014 -33.72 0 -1.52 59.72M -1.19 0 -28.76M -39.31M -39.41M 17.88M
2013 -46.75 0 -2.47 104.04M -1.15 0 -44M -41.73M -42.11M 14.53M
2012 -30.17 0 -9.74 263.8M -0.4 0 -37.25M -35.15M -27.08M 48.04M
2011 -40.63 0 -5.79 192.73M -0.47 14.74M -33.14M -32.25M -33.29M 63.75M
2010 27.54 0 6.74 103.02M 0.25 60.61M -30.62M 16.87M 15.29M 58.18M
2009 -88.92 0 -3.31 152.94M -0.56 14.73M -46.6M -44.71M -46.26M 40.22M
2008 -99.85 0 -11.81 611.32M -0.39 13.53M -5.83M -50.22M -51.78M 95.51M
2007 -80.86 0 -12.42 501.39M -0.28 7.13M -39.37M -45.26M -40.36M 100.18M
2006 -79.8 0 -15.65 555.72M -0.33 7.51M -12.04M -40.52M -35.51M 119.55M
2005 -99.25 0 -5.33 196.43M -0.47 3.78M -35.75M -37.14M -36.84M 74.01M
2004 -65.01 0 -14.52 324.6M -0.49 1.87M -16.85M -22.93M -22.35M 64.53M
2003 -128.45 0 0 0 -1.04 0 -13.11M -13.84M -14.19M 14.77M
2002 -107.39 0 0 0 -1.18 0 -10.87M -11.53M -11.87M 8.93M
2001 -72.85 0 0 0 -1.21 0 0 -8.06M -8.06M 8.83M
2000 -34.5 0 0 0 -1.56 0 0 -3.73M -3.81M 2.67M
1999 -6.79 0 0 0 0 0 0 -705K -750K 1.54M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.